Agenus, Inc. (AGEN)
6.68
+0.18
(+2.77%)
USD |
NASDAQ |
Oct 15, 16:00
6.69
+0.01
(+0.15%)
After-Hours: 20:00
Agenus Cash from Operations (TTM) : -98.50M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -98.50M |
| March 31, 2026 | -87.53M |
| December 31, 2025 | -77.20M |
| September 30, 2025 | -89.23M |
| June 30, 2025 | -127.78M |
| March 31, 2025 | -145.74M |
| December 31, 2024 | -158.32M |
| September 30, 2024 | -170.06M |
| June 30, 2024 | -182.00M |
| March 31, 2024 | -203.87M |
| December 31, 2023 | -224.20M |
| September 30, 2023 | -231.14M |
| June 30, 2023 | -198.10M |
| March 31, 2023 | -181.51M |
| December 31, 2022 | -175.37M |
| September 30, 2022 | -150.96M |
| June 30, 2022 | 12.60M |
| March 31, 2022 | 0.498M |
| December 31, 2021 | 10.14M |
| September 30, 2021 | -2.518M |
| June 30, 2021 | -165.52M |
| March 31, 2021 | -147.34M |
| December 31, 2020 | -139.10M |
| September 30, 2020 | -135.29M |
| June 30, 2020 | -131.44M |
| Date | Value |
|---|---|
| March 31, 2020 | -129.77M |
| December 31, 2019 | -18.68M |
| September 30, 2019 | -22.71M |
| June 30, 2019 | -19.43M |
| March 31, 2019 | -14.26M |
| December 31, 2018 | -131.09M |
| September 30, 2018 | -121.15M |
| June 30, 2018 | -122.79M |
| March 31, 2018 | -119.64M |
| December 31, 2017 | -94.23M |
| September 30, 2017 | -84.47M |
| June 30, 2017 | -82.15M |
| March 31, 2017 | -73.26M |
| December 31, 2016 | -79.96M |
| September 30, 2016 | -83.44M |
| June 30, 2016 | -77.63M |
| March 31, 2016 | -72.00M |
| December 31, 2015 | -47.18M |
| September 30, 2015 | -38.09M |
| June 30, 2015 | -28.19M |
| March 31, 2015 | -24.81M |
| December 31, 2014 | -38.23M |
| September 30, 2014 | -33.27M |
| June 30, 2014 | -29.60M |
| March 31, 2014 | -25.76M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 818.60M |
| Novavax, Inc. | -36.90M |
| AVITA Medical, Inc. | -24.71M |
| Iovance Biotherapeutics, Inc. | -264.18M |
| Amgen, Inc. | 12.48B |